Abstract-In this paper, a miniaturised implantable antenna with the dimensions of 8×8×1 mm 3 has been studied for continuous monitoring of Blood Glucose Levels (BGL). The antenna performance is analysed numerically for both free space and implanted operation. It has the lowest resonant frequency of 3.58 GHz in free space with a gain 1.18 GHz while operates at 2.58 GHz with a gain of 4.18 dBi when implanted. Good performance and small size make it a good for implantable glucose monitoring devices.
I. INTRODUCTION
Diabetes, the most worried threat to the modern people, has brought about substantial economic loss not only to people with them but also to the public health system and national economy system [1] . According to [2] , effective diabetes management could reduce the risk of the complications associated with the disease; therefore, real time monitoring techniques are indispensable. Among these techniques, implanted glucose sensors attract a lot of interest [3] and various implanted antenna are designed [4] - [6] , where the miniaturization of the antenna with high performances is still a great challenge. To realise such antennas, several methods like high-permittivity substrates, fractal structures, shorting pins loading and etc. have been studied [7] . The high permittivity method and split-ring resonator (SRR) is more commonly used techniques. In [5] , the miniaturization was completed realising an antenna size of 8.5×8.5×1.27 mm 3 by loading C-shaped slots and Complimentary Split-Ring Resonator (CSRR) on the radiation patch. However, there is a need to further decrease the size of the antenna to meet the requirements of continually miniaturizing implantable devices. In this paper, following the work in [5] , efforts are made to further reduce the antenna size. A smaller implantable antenna size is realised for glucose monitoring located in subcutaneous layer of the human tissues with the techniques of the CSRR and high permittivity substrates. The antenna performance is studied through numerical modelling and analysis. The paper is organized as follows: Section II presents the configuration of the proposed implantable antenna and the numerical model of the human body phantom with antenna injected in the subcutaneous layers. Schematics of the antenna and three-layer phantom with implanted antenna.
Section III gives the analysis of the antenna performance in terms of numerical results. Conclusions are drawn in Section IV.
II. ANTENNA DESIGN AND DISCUSSION

A. Antenna design
The structure of the proposed antenna is shown in Fig.  1 (a-b) while the corresponding geometrical parameters are given in Table I . The antenna is modelled and simulated using Computer Simulation Technology (CST) Microwave Studio package. The substrate and superstate used are the lossy Rogers TMM 13i ( r = 12.85, t anδ = 0.0019) with a height of 0.5 mm. The patch and ground are all considered as Perfect Electric Conductors (PEC) for simplification having the length and width of same size as the substrate and thickness of 35 µm. The antenna is fed through a 50 ohm coaxial probe. The SMA connector is also modelled as shown in Fig. 1(b) . To alleviate the effects of the human tissues, the antenna is covered in a film made of Alumina with r = 9.2, t anδ = 0.008 and a thickness of 0.02 mm.
B. Numerical Phantom Model
The in-body antenna performance is tested using a threelayer numerical phantom of size 80 × 80 × 38 mm 3 and implanting it 2 mm in the skin. The phantom consists of three layers, i.e., skin, fat, and muscle. The configuration of the phantom with electrical parameters (the relative permittivity and the conductivity [8] ) in the ISM band is shown in Fig. 1(c) . 
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III. NUMERICAL RESULTS AND ANALYSIS
The antenna performance is analysed in terms of surface current distribution, reflection coefficient, radiation pattern and gain in free space and implanted configurations. The reflection coefficient (S 11 ) response of the proposed antenna in free space and in the phantom are shown in Fig. 2 . It can be seen that the resonance frequency changes from 3.75 GHz in free space to 2.58 GHz with excellent impedance matching for the antenna in implanted condition. For the free space case, the antenna has various parasitic resonances in the higher frequency band but it has limited effect on the antenna performance when the antenna is implanted in human body. Fig. 3(a-b) shows the current distribution on the antenna surface for the two operational conditions at free space frequencies of 3.75 GHz and implanted frequency of 2.58 GHz. It shows that the current path has increased with the introduction of the slots and CSRR in the patch thus lowering the resonant frequency. The radiation patterns are observed at 3.75 GHz for the free space operation while at 2.58 GHz for the implanted scenario as illustrated in Fig. 3(c-d) . These results indicate that the antenna has good radiation coverage in both φ = 0 o and φ = 90 o planes with nearly omni-directional far-field at all the observed frequencies. More tellingly, the antenna successfully maintains the pattern shape and coverage in both the planes when implanted into the skin tissues as evident from Fig.  3(d) . The near-omnidirectionallty helps the antenna to send and receive the signal/information in all directions, hence mitigating possible body posture and shape implications. The simulated peak gain of the proposed antenna in free space is noted to be 1.8 dBi, 4.0 dBi and 5,4 dBi at 3.75 GHz, 11 GHz and 14 GHz. In implanted scenario, the gain is observed to be 4.18 dBi at 2.58 GHz. It is evident that the proposed antenna offers a good gain performance in all working conditions.
IV. CONCLUSION
A miniaturized implantable antenna has been studied for the free space and implanted conditions for continuous blood sugar monitoring. The antenna performance is analysed numerically using a three-layer human body phantom. The results have shown that good radiation coverage and a peak gain of 4.18 dBi could be obtained despite the small size of the antenna at 2.58 GHz when implanted in body. Small size, good gain and resilience to the human body effects makes the antenna a good candidate for tele-health monitoring systems.
